Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna   76545-3

LOINC Code


LOINC code76545-3
nameBreast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna
descriptionThe risk classification is an ordinal risk category (low, intermediate, high) that indicates a patient's risk of recurrence of breast cancer at 10 years. The classification is based on the 10-year risk of distant recurrence score and lymph node status. Low risk is associated with a 3% chance (confidence interval 2-6%), intermediate risk is associated with a 10% chance (confidence interval 7-14%), and high risk with a 16% chance (confidence interval 11-22%) of distant breast cancer recurrence at 10 years, respectively. [PMID: 24347518] This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
statusACTIVE

Fully-Specified Name

componentBreast cancer 10Y risk of distant recurrence classification
propertyImp  =  Impression/interpretation of study
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system^Patient
scaleOrd  =  Ordinal:  Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive.
methodProsigna

Additional Names

short nameBrst ca 10Y dist recur class Prosigna

Basic Attributes

classMOLPATH
type1  Laboratory
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

76546-1Breast cancer 10-year risk of distant recurrence panel by Prosigna

History/Usage

test rank18127 of 2000 most commonly performed tests by labs in USA
first released
last updated2.73
last change typeMIN  - change to field other than name

Related Names

breast cancer
Brst ca 10Y risk dist recur class
Impression
Impression/interpretation of study
Impressions
Interp
Interpretation
Molecular pathology
MOLPATH
Ordinal
PAM50
Point in time
Prosigna
Psoriasis Care Satisfaction questionnaire
Ql
Qual
Qualitative
Random
Screen

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.